The glass delamination not only represents a serious quality issue but also poses an adverse health risk. Small glass particles or flakes may be released from the inner surface of glass pharmaceutical container and may lead to serious health risks as embolic and thrombotic events when injected directly into a patient. This has also resulted in several product recalls. It is therefore important to conduct glass delamination studies for pharmaceutical containers to ensure that such risks are mitigated.

At VIMTA, we have been pioneers in conducting extractables and leachables testing in India, and successfully conducted a large number of glass delamination studies. Our skilled team provides a range of solutions that help mitigate risk for glass vials and syringes. This ensures that both product quality and patient safety are not compromised.